Find information on Type 2 Diabetes Mellitus with Hyperglycemia diagnosis, including ICD-10-CM codes E11.9 and E11.65, clinical documentation improvement tips, diabetes management guidelines, and healthcare provider resources. Learn about blood glucose levels, A1C testing, diabetic complications, and medical coding best practices for accurate reimbursement. This resource offers insights for physicians, nurses, coders, and other healthcare professionals involved in the diagnosis and management of Type 2 Diabetes with Hyperglycemia.
Also known as
Type 2 diabetes mellitus
Covers various manifestations of type 2 diabetes.
Type 2 DM with hyperglycemia
Specifically designates type 2 diabetes with hyperglycemia.
Hyperglycemia
Encompasses various forms of elevated blood sugar.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the patient diagnosed with Type 2 Diabetes Mellitus?
When to use each related code
| Description |
|---|
| Diabetes, Type 2 with Hyperglycemia |
| Type 2 Diabetes with Diabetic Nephropathy |
| Diabetic Peripheral Neuropathy, Type 2 |
E11.65 (Type 2 diabetes with hyperglycemia) may be missed if hyperglycemia is not explicitly documented, leading to undercoding.
Using E11.9 (Type 2 diabetes unspecified) instead of E11.65 when hyperglycemia is present results in inaccurate coding and impacts quality metrics.
Failing to code associated complications like chronic kidney disease (CKD) or retinopathy with diabetes leads to lower reimbursement and inaccurate risk adjustment.
Q: What are the latest evidence-based diagnostic criteria for Type 2 Diabetes Mellitus with Hyperglycemia, and how can I differentiate it from other forms of diabetes in my clinical practice?
A: The current gold standard for diagnosing Type 2 Diabetes Mellitus with Hyperglycemia relies on demonstrating hyperglycemia through one of several validated tests. These include a fasting plasma glucose (FPG) level of 126 mg/dL (7.0 mmol/L) or higher, a 2-hour plasma glucose level of 200 mg/dL (11.1 mmol/L) or higher during a 75-g oral glucose tolerance test (OGTT), a random plasma glucose of 200 mg/dL (11.1 mmol/L) or higher with classic symptoms of hyperglycemia (e.g., polyuria, polydipsia, unexplained weight loss), or a hemoglobin A1c (HbA1c) of 6.5% or higher. Differentiating Type 2 Diabetes Mellitus from other types like Type 1 or gestational diabetes involves assessing patient history, including age at onset, family history of diabetes, presence of autoantibodies (often absent in Type 2), and risk factors for insulin resistance. Additionally, C-peptide levels can be helpful in distinguishing Type 2 (typically normal or elevated C-peptide) from Type 1 (low or undetectable C-peptide). Consider implementing these criteria in your routine diagnostic workup for diabetes. Explore how specific clinical features, combined with laboratory results, can help accurately differentiate between various diabetes types for optimal patient management.
Q: What are the most effective non-pharmacological management strategies for patients with Type 2 Diabetes Mellitus and persistent Hyperglycemia, beyond the standard lifestyle advice?
A: Beyond the traditional advice of diet and exercise, several evidence-based non-pharmacological interventions can significantly improve hyperglycemia management in Type 2 Diabetes Mellitus. These include structured and tailored lifestyle interventions such as medically supervised weight loss programs, incorporating continuous glucose monitoring (CGM) for real-time feedback and behavioral modification, and implementing strategies for stress reduction and improved sleep hygiene. Regular physical activity beyond basic recommendations, focusing on both aerobic and resistance training, has shown significant benefits. Furthermore, referrals to registered dietitians or certified diabetes educators for individualized meal planning and carbohydrate counting can significantly contribute to improved glycemic control. Learn more about integrating advanced technologies like CGM and incorporating evidence-based behavioral modification techniques into your practice for optimal patient outcomes.
Patient presents with signs and symptoms consistent with type 2 diabetes mellitus with hyperglycemia. Presenting complaints include polyuria, polydipsia, polyphagia, and unexplained weight loss. The patient reports fatigue and blurred vision. Physical examination reveals acanthosis nigricans. Fasting blood glucose level is elevated at [insert value] mgdL, confirming the diagnosis of hyperglycemia. HbA1c is [insert value]%, further supporting the diagnosis of type 2 diabetes. Patient's BMI is [insert value] kgm2, indicating [underweight, normal weight, overweight, or obese]. Assessment includes type 2 diabetes mellitus with hyperglycemia, uncontrolled. Plan includes patient education on diabetes management, including diet, exercise, and self-monitoring of blood glucose. Metformin therapy is initiated at [insert dosage] [insert frequency]. Lifestyle modifications, including a diabetic diet and regular physical activity, are recommended. Referral to a registered dietitian and certified diabetes educator is provided for comprehensive diabetes self-management education and training. Follow-up appointment scheduled in [timeframe] to monitor glycemic control, assess treatment efficacy, and address any diabetes-related complications. Differential diagnoses considered included type 1 diabetes, gestational diabetes, and stress-induced hyperglycemia, but were ruled out based on clinical findings and laboratory results. ICD-10 code E11.9, type 2 diabetes mellitus without complications, and E11.65, type 2 diabetes mellitus with hyperglycemia, are documented. Patient advised to contact the office with any concerns or worsening of symptoms.